FOLFIRINOX + NIS793 in Pancreatic Cancer

FOLFIRINOX + NIS793 in Pancreatic Cancer
Conditions:   Pancreas Cancer;   Metastatic Pancreatic Cancer;   Metastatic Pancreatic Adenocarcinoma
Interventions:   Drug: FOLFIRINOX;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: Irinotecan;   Drug: 5-Fluorouracil (5-FU);   Drug: NIS793;   Radiation: Chemoradiation;   Drug: Capecitabine;   Radiation: Radiation Therapy;   Procedure: Surgery
Sponsors:   Colin D. Weekes, M.D.;   Novartis

Source: View full study details on

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 24, 2022Comments | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine